eCardiacRehab: a home-based, patient-centered cardiac rehab program
Official title: eCardiacRehab - a Randomized Controlled Trial on a Hybrid Home-Based Patient-Centered eHealth Programme With Tailored Solutions
Run by Haukeland University Hospital · NCT07590635 · Data updated 2026-11-12
This trial tests a hybrid home-based cardiac rehabilitation program to see if it reduces cardiovascular deaths and ED visits while improving quality of life for adults with CAD after PCI, compared with usual care.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 1000 (estimated) |
| Sponsor | Haukeland University Hospital Academic / other |
| Locations | 1 site (Bergen) |
| Status | Recruiting |
| Started | May 21, 2026 |
| Main results expected | December 31, 2027 |
| Study ends | December 31, 2037 |
| Registry record updated | June 23, 2026 |
| Trial ID | NCT07590635 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18 or older with CAD after PCI, living at home, internet access, and able to participate in a home-based program, who speak Norwegian or Scandinavian languages.
✕Probably not a fit
Patients unable to participate due to cognitive impairment, unstable medical condition, incomplete revascularization, or barriers to protocol adherence may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This multicenter randomized PROBE trial evaluates a hybrid, home-based cardiac rehabilitation program designed to be accessible to patients who may not attend traditional center-based rehab. The study compares eCardiacRehab to usual care in adults with coronary artery disease treated with PCI, focusing on cardiovascular outcomes, ED utilization, and quality of life. Secondary aims explore effects across subgroups (age, sex, hypertension, multimorbidity, mental health), medication adherence, risk factor burden, and non-inferiority to in-person rehabilitation when applicable. The trial also includes health economic analyses to assess cost-utility and overall value. Recruitment is conducted in Norway with internet-enabled participation and language considerations for Norwegian/Scandinavian speakers.
Why it matters
Potential benefit: If successful, patients could gain improved quality of life and reduced risk of CV death and emergency care, with greater access to rehabilitation regardless of location.
How similar studies have gone: Previous studies exploring home-based or hybrid cardiac rehabilitation have shown varying degrees of benefit; this trial tests a comprehensive, patient-centered approach in a real-world setting.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult Norwegian (or Scandinavian) speaking patients (≥ 18 years) who have a Norwegian national identification number * With coronary artery disease after percutaneous coronary intervention * Living at home * Have internet available * Provide signed informed consent Exclusion Criteria: * Patients with cognitive impairment that may interfere with the ability to comply with the study protocol * Severe aortic stenosis * Severe arrhythmias * Expected lifetime less than one year as determined by study personnel * Otherwise clinically unstable * Not fully revascularized * Awaits percutaneous coronary intervention or coronary artery bypass graft surgery * Inability to comply with the study protocol due to any physical disability, somatic disease, or mental problems as determined by study personnel
Where it's running
-
Haukeland University Hospital
Bergen, Norway Recruiting
Study contacts
- Principal investigator: Tone M Norekvål, PhD — Haukeland University Hospital
- Study coordinator: Trond R Pettersen, PhD
- Email: trond.roed.pettersen@helse-bergen.no
- Phone: +4748124938
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
My Symptoms Young: a web-based program for teens and young adults with persistent physical symptoms
A web-based self-help program is being tested to see if it helps 15- to 25-year-olds with persistent physical symptoms in primary care, and whether health literacy affects how well they use it.
-
TAVI and PCI vs SAVR and CABG in low- and intermediate-risk patients with severe aortic stenosis and CAD
This observational study compares TAVI plus PCI to SAVR plus CABG for patients who have both severe aortic stenosis and coronary artery disease.
-
Tailored digital support to cut sedentary time in long-term cardiac rehab
In adults in a long-term cardiac rehabilitation program, this study tests whether a personalized behavioural program with digital tools can reduce daily sitting time.
-
AI-simplified discharge summaries to improve patient understanding
This randomized pilot tests whether ContextCare can help adults understand their discharge information better than standard discharge words and printouts.
-
Healing Hearts: A Mindfulness App for Parents Navigating Divorce or Separation
A online program tests a self-guided mindfulness app for distressed parents going through divorce or separation, to see if it helps parent and child wellbeing.
-
Resveratrol and Estrogen Receptors in Postmenopausal Women with CAD
This study tests whether taking resveratrol is safe and can change estrogen-related markers in postmenopausal women with coronary artery disease.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.